Blaine A. Pfeifer, Ph.D. - Publications

Affiliations: 
2002 Stanford University, Palo Alto, CA 
Area:
Bioorganic and Biophysical Chemistry

88 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Liu X, Li K, Yu J, Ma C, Che Q, Zhu T, Li D, Pfeifer BA, Zhang G. Cyclo-diphenylalanine production in Aspergillus nidulans through stepwise metabolic engineering. Metabolic Engineering. PMID 38382797 DOI: 10.1016/j.ymben.2024.02.009  0.343
2021 Swayambhu G, Bruno M, Gulick AM, Pfeifer BA. Siderophore natural products as pharmaceutical agents. Current Opinion in Biotechnology. 69: 242-251. PMID 33640597 DOI: 10.1016/j.copbio.2021.01.021  0.337
2021 Park D, Swayambhu G, Lyga T, Pfeifer BA. Complex natural product production methods and options. Synthetic and Systems Biotechnology. 6: 1-11. PMID 33474503 DOI: 10.1016/j.synbio.2020.12.001  0.362
2021 Park D, Hill A, Pfeifer BA. Improving E. coli Bactofection by Expression of Bacteriophage ΦX174 Gene E. Methods in Molecular Biology (Clifton, N.J.). 2211: 3-14. PMID 33336266 DOI: 10.1007/978-1-0716-0943-9_1  0.337
2021 Nayerhoda R, Hill A, Pfeifer BA. Liposomal Dual Delivery of Both Polysaccharide and Protein Antigens. Methods in Molecular Biology (Clifton, N.J.). 2183: 477-487. PMID 32959261 DOI: 10.1007/978-1-0716-0795-4_26  0.324
2021 Qi R, Hill A, Pfeifer BA. A Hybrid Biological-Biomaterial Vector for Antigen Delivery. Methods in Molecular Biology (Clifton, N.J.). 2183: 461-475. PMID 32959260 DOI: 10.1007/978-1-0716-0795-4_25  0.359
2020 Qi R, Swayambhu G, Bruno M, Zhang G, Pfeifer BA. Consolidated Plasmid Design for Stabilized Heterologous Production of the Complex Natural Product Siderophore Yersiniabactin. Biotechnology Progress. e3103. PMID 33190425 DOI: 10.1002/btpr.3103  0.341
2020 Park D, Swayambhu G, Pfeifer BA. Heterologous biosynthesis as a platform for producing new generation natural products. Current Opinion in Biotechnology. 66: 123-130. PMID 32784020 DOI: 10.1016/J.Copbio.2020.06.014  0.47
2020 Swayambhu G, Moscatello N, Atilla-Gokcumen GE, Pfeifer BA. Flux Balance Analysis for Media Optimization and Genetic Targets to Improve Heterologous Siderophore Production. Iscience. 23: 101016. PMID 32279062 DOI: 10.1016/J.Isci.2020.101016  0.474
2020 Jafari A, Rajabian N, Zhang G, Alaa Mohamed M, Lei P, Andreadis ST, Pfeifer BA, Cheng C. PEGylated Amine-Functionalized Poly(ε-caprolactone) for the Delivery of Plasmid DNA. Materials (Basel, Switzerland). 13. PMID 32085401 DOI: 10.3390/Ma13040898  0.312
2019 Liu X, Hua K, Liu D, Wu ZL, Wang Y, Zhang H, Deng Z, Pfeifer BA, Jiang M. Heterologous Biosynthesis of Type II Polyketide Products Using E. coli. Acs Chemical Biology. PMID 31825590 DOI: 10.1021/Acschembio.9B00827  0.479
2019 Nayerhoda R, Hill A, Beitelshees M, Jones C, Pfeifer B. Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System. Materials (Basel, Switzerland). 12. PMID 31480544 DOI: 10.3390/Ma12172809  0.305
2018 Qi R, Pfeifer BA, Zhang G. Engineering Heterologous Production of Salicylate Glucoside and Glycosylated Variants. Frontiers in Microbiology. 9: 2241. PMID 30294315 DOI: 10.3389/Fmicb.2018.02241  0.467
2018 Hill A, Beitelshees M, Nayerhoda R, Pfeifer BA, Jones C. Engineering a next-generation glycoconjugate-like Streptococcus pneumoniae vaccine. Acs Infectious Diseases. PMID 30180541 DOI: 10.1021/Acsinfecdis.8B00100  0.314
2018 Hill A, Beitelshees M, Pfeifer BA, Jones CH. Standardizing pneumococcal biofilm release to PncO expression, a predictive measurement of virulence. Infection and Immunity. PMID 29986896 DOI: 10.1128/Iai.00494-18  0.337
2018 Beitelshees M, Hill A, Jones CH, Pfeifer BA. Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design. Materials (Basel, Switzerland). 11. PMID 29949876 DOI: 10.3390/Ma11071086  0.322
2018 Fang L, Zhang G, El-Halfawy O, Simon M, Brown ED, Pfeifer BA. Broadened glycosylation patterning of heterologously produced erythromycin. Biotechnology and Bioengineering. PMID 29873068 DOI: 10.1002/Bit.26735  0.549
2018 Matich EK, Ghafari M, Camgoz E, Caliskan E, Pfeifer BA, Haznedaroglu BZ, Atilla-Gokcumen GE. Time-series lipidomic analysis of the oleaginous green microalga speciesunder nutrient stress. Biotechnology For Biofuels. 11: 29. PMID 29441127 DOI: 10.1186/S13068-018-1026-Y  0.318
2018 Liu X, Liu D, Xu M, Tao M, Bai L, Deng Z, Pfeifer BA, Jiang M. Reconstitution of Kinamycin Biosynthesis within the Heterologous Host Streptomyces albus J1074. Journal of Natural Products. PMID 29338229 DOI: 10.1021/Acs.Jnatprod.7B00652  0.426
2018 Beitelshees M, Hill A, Rostami P, Jones CH, Pfeifer BA. A Transition to Targeted or ‘Smart’ Vaccines: How Understanding Commensal Colonization Can Lead to Selective Vaccination Pharmaceutical Medicine. 32: 95-102. DOI: 10.1007/S40290-018-0225-Y  0.322
2018 Moscatello N, Pfeifer BA. Constraint-based metabolic targets for the improved production of heterologous compounds across molecular classification Aiche Journal. 64: 4208-4217. DOI: 10.1002/Aic.16343  0.379
2017 Fang L, Guell M, Church GM, Pfeifer BA. Heterologous Erythromycin Production across Strain and Plasmid Construction. Biotechnology Progress. PMID 28960932 DOI: 10.1002/Btpr.2567  0.596
2017 Moscatello N, Qi R, Ahmadi MK, Pfeifer BA. Increased Production of Yersiniabactin and an Anthranilate Analog through Media Optimization. Biotechnology Progress. PMID 28547883 DOI: 10.1002/Btpr.2496  0.399
2016 Chitgupi U, Li Y, Chen M, Shao S, Beitelshees M, Tan MJ, Neelamegham S, Pfeifer BA, Jones C, Lovell JF. Bimodal Targeting Using Sulfonated, Mannosylated PEI for Combined Gene Delivery and Photodynamic Therapy. Photochemistry and Photobiology. PMID 27935058 DOI: 10.1111/Php.12688  0.305
2016 Pfeifer BA, Tang Y. Editorial overview: Pharmaceutical biotechnology: New approaches for dynamic disease targets. Current Opinion in Biotechnology. PMID 27856096 DOI: 10.1016/J.Copbio.2016.11.002  0.504
2016 Ahmadi MK, Fang L, Moscatello N, Pfeifer BA. E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent. Metabolic Engineering. PMID 27718358 DOI: 10.1016/J.Ymben.2016.10.001  0.546
2016 Ahmadi MK, Pfeifer BA. Improved Heterologous Production of the Nonribosomal Peptide-Polyketide Siderophore Yersiniabactin through Metabolic Engineering and Induction Optimization. Biotechnology Progress. PMID 27681485 DOI: 10.1002/Btpr.2369  0.488
2016 Li Y, Beitelshees M, Fang L, Hill A, Ahmadi MK, Chen M, Davidson BA, Knight P, Smith RJ, Andreadis ST, Hakansson AP, Jones CH, Pfeifer BA. In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector. Science Advances. 2: e1600264. PMID 27419235 DOI: 10.1126/Sciadv.1600264  0.512
2016 Li Y, Hill A, Beitelshees M, Shao S, Lovell JF, Davidson BA, Knight PR, Hakansson AP, Pfeifer BA, Jones CH. Directed vaccination against pneumococcal disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 27274071 DOI: 10.1073/Pnas.1603007113  0.306
2016 Ahmadi MK, Pfeifer BA. Recent progress in therapeutic natural product biosynthesis using Escherichia coli. Current Opinion in Biotechnology. 42: 7-12. PMID 26942861 DOI: 10.1016/J.Copbio.2016.02.010  0.513
2016 Zhang H, Fang L, Osburne MS, Pfeifer BA. The Continuing Development of E. coli as a Heterologous Host for Complex Natural Product Biosynthesis. Methods in Molecular Biology (Clifton, N.J.). 1401: 121-34. PMID 26831705 DOI: 10.1007/978-1-4939-3375-4_8  0.611
2016 Ahmadi MK, Fawaz S, Pfeifer BA. An aqueous two-phase system to pre-purify a heterologously produced siderophore Technology. 4: 135-138. DOI: 10.1142/s2339547815400117  0.348
2015 Hill AB, Chen M, Chen CK, Pfeifer BA, Jones CH. Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors. Trends in Biotechnology. PMID 26727153 DOI: 10.1016/J.Tibtech.2015.11.004  0.335
2015 Zhang G, Li Y, Fang L, Pfeifer BA. Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli. Science Advances. 1: e1500077. PMID 26601183 DOI: 10.1126/Sciadv.1500077  0.578
2015 Ahmadi MK, Fawaz S, Fang L, Yu Z, Pfeifer BA. Molecular variation of the nonribosomal peptide-polyketide siderophore yersiniabactin through biosynthetic and metabolic engineering. Biotechnology and Bioengineering. PMID 26524346 DOI: 10.1002/Bit.25872  0.594
2015 Kumpfmüller J, Methling K, Fang L, Pfeifer BA, Lalk M, Schweder T. Production of the polyketide 6-deoxyerythronolide B in the heterologous host Bacillus subtilis. Applied Microbiology and Biotechnology. PMID 26432460 DOI: 10.1007/S00253-015-6990-6  0.564
2015 Ahmadi MK, Fawaz S, Jones CH, Zhang G, Pfeifer BA. Total Biosynthesis and Diverse Applications of the Nonribosomal Peptide-Polyketide Siderophore Yersiniabactin. Applied and Environmental Microbiology. 81: 5290-8. PMID 26025901 DOI: 10.1128/Aem.01373-15  0.382
2015 Jones CH, Gollakota A, Chen M, Chung TC, Ravikrishnan A, Zhang G, Pfeifer BA. Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene delivery. Biomaterials. 58: 103-11. PMID 25941787 DOI: 10.1016/J.Biomaterials.2015.04.033  0.352
2015 Chung TC, Jones CH, Gollakota A, Kamal Ahmadi M, Rane S, Zhang G, Pfeifer BA. Improved Escherichia coli Bactofection and Cytotoxicity by Heterologous Expression of Bacteriophage ΦX174 Lysis Gene E. Molecular Pharmaceutics. 12: 1691-700. PMID 25849744 DOI: 10.1021/Acs.Molpharmaceut.5B00172  0.437
2015 Jones CH, Chen M, Gollakota A, Ravikrishnan A, Zhang G, Lin S, Tan M, Cheng C, Lin H, Pfeifer BA. Structure-Function Assessment of Mannosylated Poly(β-amino esters) upon Targeted Antigen Presenting Cell Gene Delivery. Biomacromolecules. 16: 1534-41. PMID 25848953 DOI: 10.1021/Acs.Biomac.5B00062  0.333
2015 Jones CH, Chen CK, Chen M, Ravikrishnan A, Zhang H, Gollakota A, Chung T, Cheng C, Pfeifer BA. PEGylated cationic polylactides for hybrid biosynthetic gene delivery. Molecular Pharmaceutics. 12: 846-56. PMID 25625426 DOI: 10.1021/Mp500683C  0.38
2015 Li Y, Zhang G, Pfeifer BA. Current and emerging options for taxol production. Advances in Biochemical Engineering/Biotechnology. 148: 405-25. PMID 25528175 DOI: 10.1007/10_2014_292  0.452
2015 Jones CH, Chen M, Ravikrishnan A, Reddinger R, Zhang G, Hakansson AP, Pfeifer BA. Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation. Biomaterials. 37: 333-44. PMID 25453962 DOI: 10.1016/J.Biomaterials.2014.10.037  0.355
2014 Jones CH, Ravikrishnan A, Chen M, Reddinger R, Kamal Ahmadi M, Rane S, Hakansson AP, Pfeifer BA. Hybrid biosynthetic gene therapy vector development and dual engineering capacity. Proceedings of the National Academy of Sciences of the United States of America. 111: 12360-5. PMID 25114239 DOI: 10.1073/Pnas.1411355111  0.4
2014 Li Y, Pfeifer BA. Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology. Current Opinion in Plant Biology. 19: 8-13. PMID 24631884 DOI: 10.1016/J.Pbi.2014.02.005  0.477
2014 Zhang G, Pfeifer BA. Production of Therapeutic Products Natural Products: Discourse, Diversity, and Design. 261-276. DOI: 10.1002/9781118794623.ch14  0.302
2013 Jones CH, Rane S, Patt E, Ravikrishnan A, Chen CK, Cheng C, Pfeifer BA. Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity. Molecular Pharmaceutics. 10: 4301-8. PMID 24093973 DOI: 10.1021/Mp4003927  0.384
2013 Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA. Overcoming nonviral gene delivery barriers: perspective and future. Molecular Pharmaceutics. 10: 4082-98. PMID 24093932 DOI: 10.1021/Mp400467X  0.344
2013 Jiang M, Zhang H, Park SH, Li Y, Pfeifer BA. Deoxysugar pathway interchange for erythromycin analogues heterologously produced through Escherichia coli. Metabolic Engineering. 20: 92-100. PMID 24060454 DOI: 10.1016/J.Ymben.2013.09.005  0.434
2013 Chen CK, Jones CH, Mistriotis P, Yu Y, Ma X, Ravikrishnan A, Jiang M, Andreadis ST, Pfeifer BA, Cheng C. Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery. Biomaterials. 34: 9688-99. PMID 24034497 DOI: 10.1016/J.Biomaterials.2013.08.063  0.324
2013 Jiang M, Fang L, Pfeifer BA. Improved heterologous erythromycin A production through expression plasmid re-design. Biotechnology Progress. 29: 862-9. PMID 23804312 DOI: 10.1002/Btpr.1759  0.619
2013 Jiang M, Pfeifer BA. Metabolic and pathway engineering to influence native and altered erythromycin production through E. coli. Metabolic Engineering. 19: 42-9. PMID 23747605 DOI: 10.1016/J.Ymben.2013.05.005  0.471
2013 Rucker J, Paul J, Pfeifer BA, Lee K. Engineering E. coli for triglyceride accumulation through native and heterologous metabolic reactions. Applied Microbiology and Biotechnology. 97: 2753-9. PMID 23404315 DOI: 10.1007/S00253-013-4714-3  0.422
2013 Jiang M, Zhang H, Pfeifer BA. The logic, experimental steps, and potential of heterologous natural product biosynthesis featuring the complex antibiotic erythromycin A produced through E. coli. Journal of Visualized Experiments : Jove. e4346. PMID 23354010 DOI: 10.3791/4346  0.514
2013 Jones CH, Chen CK, Jiang M, Fang L, Cheng C, Pfeifer BA. Synthesis of cationic polylactides with tunable charge densities as nanocarriers for effective gene delivery. Molecular Pharmaceutics. 10: 1138-45. PMID 23339525 DOI: 10.1021/Mp300666S  0.453
2012 Jiang M, Stephanopoulos G, Pfeifer BA. Downstream reactions and engineering in the microbially reconstituted pathway for Taxol. Applied Microbiology and Biotechnology. 94: 841-9. PMID 22460591 DOI: 10.1007/S00253-012-4016-1  0.449
2012 Jiang M, Stephanopoulos G, Pfeifer BA. Toward biosynthetic design and implementation of Escherichia coli-derived paclitaxel and other heterologous polyisoprene compounds. Applied and Environmental Microbiology. 78: 2497-504. PMID 22287010 DOI: 10.1128/Aem.07391-11  0.452
2012 Boghigian BA, Armando J, Salas D, Pfeifer BA. Computational identification of gene over-expression targets for metabolic engineering of taxadiene production. Applied Microbiology and Biotechnology. 93: 2063-73. PMID 22124721 DOI: 10.1007/S00253-011-3725-1  0.445
2012 Zhang H, Skalina K, Jiang M, Pfeifer BA. Improved E. coli erythromycin A production through the application of metabolic and bioprocess engineering. Biotechnology Progress. 28: 292-6. PMID 21905273 DOI: 10.1002/Btpr.702  0.427
2012 Boghigian BA, Salas D, Ajikumar PK, Stephanopoulos G, Pfeifer BA. Analysis of heterologous taxadiene production in K- and B-derived Escherichia coli. Applied Microbiology and Biotechnology. 93: 1651-61. PMID 21850432 DOI: 10.1007/S00253-011-3528-4  0.418
2012 Jiang M, Zhang H, Boghigian B, Wang Y, Pfeifer B. Heterologous biosynthesis as a route to complex polyketide and isoprenoid natural products Planta Medica. 78. DOI: 10.1055/S-0032-1320300  0.401
2011 Boghigian BA, Myint M, Wu J, Pfeifer BA. Simultaneous production and partitioning of heterologous polyketide and isoprenoid natural products in an Escherichia coli two-phase bioprocess. Journal of Industrial Microbiology & Biotechnology. 38: 1809-20. PMID 21487833 DOI: 10.1007/S10295-011-0969-9  0.476
2011 Boghigian BA, Zhang H, Pfeifer BA. Multi-factorial engineering of heterologous polyketide production in Escherichia coli reveals complex pathway interactions. Biotechnology and Bioengineering. 108: 1360-71. PMID 21337322 DOI: 10.1002/Bit.23069  0.44
2011 Zhang H, Boghigian BA, Armando J, Pfeifer BA. Methods and options for the heterologous production of complex natural products. Natural Product Reports. 28: 125-51. PMID 21060956 DOI: 10.1039/C0Np00037J  0.433
2010 Zhang H, Wang Y, Wu J, Skalina K, Pfeifer BA. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chemistry & Biology. 17: 1232-40. PMID 21095573 DOI: 10.1016/J.Chembiol.2010.09.013  0.45
2010 Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (New York, N.Y.). 330: 70-4. PMID 20929806 DOI: 10.1126/Science.1191652  0.435
2010 Wu J, Boghigian BA, Myint M, Zhang H, Zhang S, Pfeifer BA. Construction and performance of heterologous polyketide-producing K-12- and B-derived Escherichia coli. Letters in Applied Microbiology. 51: 196-204. PMID 20565574 DOI: 10.1111/J.1472-765X.2010.02880.X  0.478
2010 Boghigian BA, Shi H, Lee K, Pfeifer BA. Utilizing elementary mode analysis, pathway thermodynamics, and a genetic algorithm for metabolic flux determination and optimal metabolic network design. Bmc Systems Biology. 4: 49. PMID 20416071 DOI: 10.1186/1752-0509-4-49  0.425
2010 Boghigian BA, Seth G, Kiss R, Pfeifer BA. Metabolic flux analysis and pharmaceutical production. Metabolic Engineering. 12: 81-95. PMID 19861167 DOI: 10.1016/J.Ymben.2009.10.004  0.378
2010 Boghigian BA, Lee K, Pfeifer BA. Computational analysis of phenotypic space in heterologous polyketide biosynthesis--applications to Escherichia coli, Bacillus subtilis, and Saccharomyces cerevisiae. Journal of Theoretical Biology. 262: 197-207. PMID 19833139 DOI: 10.1016/J.Jtbi.2009.10.006  0.516
2010 Zhang H, Boghigian BA, Pfeifer BA. Investigating the role of native propionyl-CoA and methylmalonyl-CoA metabolism on heterologous polyketide production in Escherichia coli. Biotechnology and Bioengineering. 105: 567-73. PMID 19806677 DOI: 10.1002/Bit.22560  0.479
2009 Zhang H, Wang Y, Boghigian B, Pfeifer BA. Probing the heterologous metabolism supporting 6-deoxyerythronolide B biosynthesis in Escherichia coli. Microbial Biotechnology. 2: 390-4. PMID 21261933 DOI: 10.1111/J.1751-7915.2009.00099.X  0.478
2009 Pistorino M, Pfeifer BA. Efficient experimental design and micro-scale medium enhancement of 6-deoxyerythronolide B production through Escherichia coli. Biotechnology Progress. 25: 1364-71. PMID 19634176 DOI: 10.1002/Btpr.250  0.465
2008 Parsa S, Wang Y, Rines K, Pfeifer BA. A high-throughput comparison of recombinant gene expression parameters for E. coli-mediated gene transfer to P388D1 macrophage cells. Journal of Biotechnology. 137: 59-64. PMID 18694790 DOI: 10.1016/J.Jbiotec.2008.07.1815  0.363
2008 Boghigian BA, Pfeifer BA. Current status, strategies, and potential for the metabolic engineering of heterologous polyketides in Escherichia coli. Biotechnology Letters. 30: 1323-30. PMID 18488149 DOI: 10.1007/S10529-008-9689-2  0.49
2008 Pfeifer B. Natural products and production systems: opening comments. Molecular Pharmaceutics. 5: 165-6. PMID 18302320 DOI: 10.1021/Mp8000183  0.392
2008 Zhang H, Wang Y, Pfeifer BA. Bacterial hosts for natural product production. Molecular Pharmaceutics. 5: 212-25. PMID 18232637 DOI: 10.1021/Mp7001329  0.48
2008 Wang Y, Pfeifer BA. 6-deoxyerythronolide B production through chromosomal localization of the deoxyerythronolide B synthase genes in E. coli. Metabolic Engineering. 10: 33-8. PMID 17959404 DOI: 10.1016/J.Ymben.2007.09.002  0.42
2007 Wang Y, Boghigian BA, Pfeifer BA. Improving heterologous polyketide production in Escherichia coli by overexpression of an S-adenosylmethionine synthetase gene. Applied Microbiology and Biotechnology. 77: 367-73. PMID 17876579 DOI: 10.1007/S00253-007-1172-9  0.476
2007 Parsa S, Pfeifer B. Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells Molecular Pharmaceutics. 4: 4-17. PMID 17233543 DOI: 10.1021/Mp0600889  0.367
2003 Pfeifer BA, Wang CC, Walsh CT, Khosla C. Biosynthesis of Yersiniabactin, a complex polyketide-nonribosomal peptide, using Escherichia coli as a heterologous host. Applied and Environmental Microbiology. 69: 6698-702. PMID 14602630 DOI: 10.1128/Aem.69.11.6698-6702.2003  0.646
2003 Kinoshita K, Pfeifer BA, Khosla C, Cane DE. Precursor-Directed polyketide biosynthesis in Escherichia coli. Bioorganic & Medicinal Chemistry Letters. 13: 3701-4. PMID 14552761 DOI: 10.1016/J.Bmcl.2003.08.008  0.556
2003 Hu Z, Pfeifer BA, Chao E, Murli S, Kealey J, Carney JR, Ashley G, Khosla C, Hutchinson CR. A specific role of the Saccharopolyspora erythraea thioesterase II gene in the function of modular polyketide synthases. Microbiology (Reading, England). 149: 2213-25. PMID 12904561 DOI: 10.1099/Mic.0.26015-0  0.559
2002 Pfeifer B, Hu Z, Licari P, Khosla C. Process and metabolic strategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B. Applied and Environmental Microbiology. 68: 3287-92. PMID 12089005 DOI: 10.1128/Aem.68.7.3287-3292.2002  0.611
2002 Dayem LC, Carney JR, Santi DV, Pfeifer BA, Khosla C, Kealey JT. Metabolic engineering of a methylmalonyl-CoA mutase-epimerase pathway for complex polyketide biosynthesis in Escherichia coli. Biochemistry. 41: 5193-201. PMID 11955068 DOI: 10.1021/Bi015593K  0.555
2001 Lombó F, Pfeifer B, Leaf T, Ou S, Kim YS, Cane DE, Licari P, Khosla C. Enhancing the atom economy of polyketide biosynthetic processes through metabolic engineering. Biotechnology Progress. 17: 612-7. PMID 11485419 DOI: 10.1021/Bp010045J  0.608
2001 Pfeifer BA, Khosla C. Biosynthesis of polyketides in heterologous hosts. Microbiology and Molecular Biology Reviews : Mmbr. 65: 106-18. PMID 11238987 DOI: 10.1128/Mmbr.65.1.106-118.2001  0.588
2001 Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science (New York, N.Y.). 291: 1790-2. PMID 11230695 DOI: 10.1126/Science.1058092  0.606
Show low-probability matches.